MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

Tonini, G P; Boni, L; Pession, A; Rogers, D; Iolascon, A; Basso, G; Cordero di Montezemolo, L; Casale, F; Pession, A; Perri, P; Mazzocco, K; Scaruffi, P; Lo Cunsolo, C; Marchese, N; Milanaccio, C; Conte, M; Bruzzi, P; De Bernardi, B

Tonini, G P; Boni, L; Pession, A; Rogers, D; Iolascon, A; Basso, G; Cordero di Montezemolo, L; Casale, F; Pession, A; Perri, P; Mazzocco, K; Scaruffi, P; Lo Cunsolo, C; Marchese, N; Milanaccio, C; Conte, M; Bruzzi, P; De Bernardi, B.

Affiliation

Tonini GP; Department of Hematology-Oncology, Giannina Gaslini Children's Hospital, Genova, Italy. tonini@cba.uniqe.it

J Clin Oncol ; 15(1): 85-93, 1997 Jan.

Article in En | MEDLINE | ID: mdl-8996128

Subject(s)

Gene Amplification/genetics; Genes, myc/genetics; Neuroblastoma/genetics; Adolescent; Biomarkers, Tumor/blood; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Neuroblastoma/blood; Neuroblastoma/pathology; Prognosis

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Gene Amplification / Genes, myc / Neuroblastoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Language: En Year: 1997 Type: Article

Search on Google

XML

PubMed Links